HopeStage
Back to all studies
CompletedNCT01734278

Real-World Use and Short-Term Safety of Asenapine

About this titleRead the official source — NCT01734278
Observational studyAges 18+United KingdomBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
StaffordSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2012
Recruitment status
Completed
Enrollment listed in the registry
1,000
Sponsor
Professor Saad Shakir
Sponsor type
Individual investigator
Study type
Observational
Intervention type
Other
Locations
United Kingdom
Age range
Over 18 Years
Official registry ID
NCT01734278
Official title
Show the full official title

An Observational Post-Authorisation Safety Specialist Cohort Monitoring Study (SCEM) to Monitor the Safety and Utilisation of Asenapine (Sycrest) in the Mental Health Trust Setting in England

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Stafford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Professor Saad Shakir.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies